ARTICLE | Clinical News
Alethia preclinical data
December 14, 2009 8:00 AM UTC
In a mouse model of metastatic cancer, AB-16B5 plus Taxotere docetaxel increased tumor growth inhibition by 40-60% vs. chemotherapy alone. In a mouse model of breast carcinoma, AB-16B5 reduced metast...